$7.15
-0.12-1.65%
Last update: Apr 20, 2:57 PM
Vanda Pharmaceuticals Inc Earnings Estimates
VNDANASDAQ
Vanda Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VNDA
Vanda Pharmaceuticals (VNDA) is scheduled to report Q1 earnings on May 6, 2026. Analysts estimate EPS of $-0.62 and quarterly revenue of $55.87M.
In the most recent quarter (Q4), Vanda Pharmaceuticals reported EPS of $-2.39, missing estimates of $-1.67 by 0.43%. Revenue came in at $57.22M, missing the estimate of $59.10M by 0.03%.
Over the last 4 quarters, Vanda Pharmaceuticals has averaged an EPS surprise of 6.21% and a revenue surprise of 0.06%.
Earnings Date
May 6
EPS Estimate
$-0.620
Quarterly Revenue Estimate
$55.87M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$216.10M
Vanda Pharmaceuticals Earnings History
Analyze the earnings history of Vanda Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Vanda Pharmaceuticals (VNDA) Earnings Per Share
The chart below shows Vanda Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Vanda Pharmaceuticals (VNDA) Revenue
The chart below shows Vanda Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Vanda Pharmaceuticals (NASDAQ:VNDA) reporting earnings?
Vanda Pharmaceuticals (VNDA) is scheduled to report earnings on May 6, 2026. The last reported earnings were for reported on February 11, 2026 for Q4.
What were the latest earnings per share (EPS) for Vanda Pharmaceuticals (NASDAQ:VNDA)?
The Actual EPS was $-2.39, which missed the estimate of $-1.67.
What were Vanda Pharmaceuticals’s (NASDAQ:VNDA) revenues?
The Actual Revenue was $57.22M, which missed the estimate of $59.10M.
